supp.fit

Vitamin E, Omega-3 Fatty Acids and Docosahexaenoic Acid: study protocols

7 study groups took Vitamin E together with Omega-3 Fatty Acids and Docosahexaenoic Acid. These are the doses the studies gave. They are not a recommendation.

Vitamin E: what the research found →

Dose per serving from research: Vitamin E

7 study groups in 6 studies say how much Vitamin E participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 mg to 2.5 mg and 5 mg to 10 mg and 500 mg to 1 g, 29% of 7 study groups each.

Daily doseStudy groups
1 mg to 2.5 mg
2
2.5 mg to 5 mg
0
5 mg to 10 mg
2
10 mg to 25 mg
0
25 mg to 50 mg
0
50 mg to 100 mg
0
100 mg to 250 mg
1
250 mg to 500 mg
0
500 mg to 1 g
2

Dose per serving from research: Omega-3 Fatty Acids

7 study groups in 6 studies say how much Omega-3 Fatty Acids participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 57% of 7 study groups.

Daily doseStudy groups
250 mg to 500 mg
1
500 mg to 1 g
2
1 g to 2.5 g
4

Dose per serving from research: Docosahexaenoic Acid

7 study groups in 6 studies say how much Docosahexaenoic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 43% of 7 study groups.

Daily doseStudy groups
500 mg or less
1
500 mg to 1 g
3
1 g to 2.5 g
1
2.5 g to 5 g
2

Commonly used together

4 of 7 study groups took Vitamin E, Omega-3 Fatty Acids and Docosahexaenoic Acid with something else, but nothing that 3 or more different studies gave.

7 study groups

Study
CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study
2015 · DHA group · Adults aged 55–85 with early AMD in the study eye and neovascular AMD in the fellow eye
6 mg270 mg840 mg3 years127
Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents
1996 · First group: fish oil followed by placebo · Adolescent girls with dysmenorrhea
1.5 mg1.08 g720 mg60 days21
Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents
1996 · Second group: placebo followed by fish oil · Adolescent girls with dysmenorrhea
1.5 mg1.08 g720 mg60 days21
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
2015 · ω-3 PUFA group · People aged 13–25 with ultra-high risk for psychosis
7.6 mg1.42 g480 mg12 weeks40
The Effects of a 6-Month High Dose Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins Supplementation on Cognitive Function and Functional Capacity in Older Adults with Mild Cognitive Impairment
2020 · omega supplementation group · Adults aged 65 years or older with mild cognitive impairment
782 mg810 mg4.14 g26 weeks23
Neuroaspis PLP10™, a nutritional formula rich in omega-3 and omega-6 fatty acids with antioxidant vitamins including gamma-tocopherol in early Parkinson's disease: A randomized, double-blind, placebo-controlled trial
2021 · Neuroaspis PLP10™ · Patients with Parkinson's disease; age and sex not reported.
782 mg810 mg4.14 g913 days20
Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions
2000 · fish oil (FO) · Healthy subjects; age and sex not specified
205 mg2.1 g1.1 g12 weeks—